GM07767/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1981	1
1982	1
1983	2
1984	1
1985	1
1986	2
1987	2
1988	1
1990	2
1991	3
1992	7
1993	6
1994	7
1995	10
1996	8
1997	5
1998	13
1999	8
2000	14
2001	11
2002	8
2003	13
2004	20
2005	20
2006	20
2007	9
2008	6
2009	11
2010	4
2011	7
2012	4
2013	2
2014	2
2015	1
2020	1
2025	0

1

Recent advances in protein prenyltransferases: substrate identification, regulation, and disease interventions.

Zverina EA, Lamphear CL, Wright EN, Fierke CA. Zverina EA, et al. Curr Opin Chem Biol. 2012 Dec;16(5-6):544-52. doi: 10.1016/j.cbpa.2012.10.015. Epub 2012 Nov 8. Curr Opin Chem Biol. 2012. PMID: 23141597 Free PMC article. Review.

2

Protein flexibility in docking and surface mapping.

Lexa KW, Carlson HA. Lexa KW, et al. Q Rev Biophys. 2012 Aug;45(3):301-43. doi: 10.1017/S0033583512000066. Epub 2012 May 9. Q Rev Biophys. 2012. PMID: 22569329 Free PMC article. Review.

3

Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

Narasimhan D, Woods JH, Sunahara RK. Narasimhan D, et al. Future Med Chem. 2012 Feb;4(2):137-50. doi: 10.4155/fmc.11.194. Future Med Chem. 2012. PMID: 22300094 Free PMC article. Review.

4

Behavioral effects of delta-opioid receptor agonists: potential antidepressants?

Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Broom DC, et al. Jpn J Pharmacol. 2002 Sep;90(1):1-6. doi: 10.1254/jjp.90.1. Jpn J Pharmacol. 2002. PMID: 12396021 Free article. Review.

5

Reaction crystallization of pharmaceutical molecular complexes.

Rodríguez-Hornedo N, Nehm SJ, Seefeldt KF, Pagan-Torres Y, Falkiewicz CJ. Rodríguez-Hornedo N, et al. Mol Pharm. 2006 May-Jun;3(3):362-7. doi: 10.1021/mp050099m. Mol Pharm. 2006. PMID: 16749868

6

Transglycosylation: a mechanism for RNA modification (and editing?).

Garcia GA, Kittendorf JD. Garcia GA, et al. Bioorg Chem. 2005 Jun;33(3):229-51. doi: 10.1016/j.bioorg.2005.01.001. Epub 2005 Feb 23. Bioorg Chem. 2005. PMID: 15888313 Free PMC article. Review.

7

Proteolytic degradation of nitric oxide synthase: effect of inhibitors and role of hsp90-based chaperones.

Osawa Y, Lowe ER, Everett AC, Dunbar AY, Billecke SS. Osawa Y, et al. J Pharmacol Exp Ther. 2003 Feb;304(2):493-7. doi: 10.1124/jpet.102.035055. J Pharmacol Exp Ther. 2003. PMID: 12538799 Review.

8

The antidepressant -like effects of delta-opioid receptor agonists.

Jutkiewicz EM. Jutkiewicz EM. Mol Interv. 2006 Jun;6(3):162-9. doi: 10.1124/mi.6.3.7. Mol Interv. 2006. PMID: 16809477 Review.

9

Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.

Lee KO, Akil H, Woods JH, Traynor JR. Lee KO, et al. Eur J Pharmacol. 1999 Aug 13;378(3):323-30. doi: 10.1016/s0014-2999(99)00460-4. Eur J Pharmacol. 1999. PMID: 10493109

10

Cobalamin-dependent and cobalamin-independent methionine synthases in Escherichia coli: two solutions to the same chemical problem.

Drummond JT, Matthews RG. Drummond JT, et al. Adv Exp Med Biol. 1993;338:687-92. doi: 10.1007/978-1-4615-2960-6_142. Adv Exp Med Biol. 1993. PMID: 8304207 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Results by year